A Real-life experience with Eculizumab and Efgartigimod in generalized Myasthenia Gravis patients

被引:0
|
作者
Sacca, F. [1 ]
Cuomo, N. [1 ]
Russo, C. [1 ]
Campanile, M. [1 ]
Puorro, G. [1 ]
Marsili, A. [1 ]
Pane, C. [1 ]
机构
[1] Univ Naples Federico II, NSRO Dept, Naples, Italy
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
EPO-389
引用
收藏
页码:569 / 569
页数:1
相关论文
共 50 条
  • [1] A real-life experience with eculizumab and efgartigimod in generalized myasthenia gravis patients
    Pane, Chiara
    Di Stefano, Vincenzo
    Cuomo, Nunzia
    Sarnataro, Alessio
    Vinciguerra, Claudia
    Bevilacqua, Liliana
    Brighina, Filippo
    Rini, Nicasio
    Puorro, Giorgia
    Marsili, Angela
    Garibaldi, Matteo
    Fionda, Laura
    Sacca, Francesco
    JOURNAL OF NEUROLOGY, 2024, : 6209 - 6219
  • [2] A Real-life experience with Eculizumab and Efgartigimod in generalized Myasthenia Gravis patients.
    Sacca, F.
    Pane, C.
    Espinosa, P.
    Sormani, M.
    Signori, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 569 - 570
  • [3] Efgartigimod in generalized myasthenia gravis: A real-life experience at a national reference center
    Frangiamore, Rita
    Rinaldi, Elena
    Vanoli, Fiammetta
    Andreetta, Francesca
    Ciusani, Emilio
    Bonanno, Silvia
    Maggi, Lorenzo
    Gallone, Annamaria
    Colasuonno, Anna
    Tramacere, Irene
    Cheli, Marta
    Pinna, Alessandro
    Mantegazza, Renato
    Antozzi, Carlo
    EUROPEAN JOURNAL OF NEUROLOGY, 2024, 31 (04)
  • [4] The effectiveness and value of eculizumab and efgartigimod for generalized myasthenia gravis
    Tice, Jeffrey A.
    Touchette, Daniel R.
    Lien, Pei-Wen
    Agboola, Foluso
    Nikitin, Dmitriy
    Pearson, Steven D.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2022, 28 (01): : 119 - 124
  • [5] Real-World experience with efgartigimod in patients with myasthenia gravis
    Fuchs, Lior
    Shelly, Shahar
    Vigiser, Ifat
    Kolb, Hadar
    Regev, Keren
    Schwartzmann, Yoel
    Vaknin-Dembinsky, Adi
    Dori, Amir
    Karni, Arnon
    JOURNAL OF NEUROLOGY, 2024, 271 (06) : 3462 - 3470
  • [6] A real world experience with Efgartigimod in generalized Myasthenia Gravis in a national reference center
    Antozzi, C.
    Frangiamore, R.
    Rinaldi, E.
    Vanoli, F.
    Andreetta, F.
    Ciusani, E.
    Bonanno, S.
    Maggi, L.
    Gallone, A.
    Pinna, A.
    Mantegazza, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 204 - 204
  • [7] Real-world experience with eculizumab and switching to ravulizumab for generalized myasthenia gravis
    Tokuyasu, Daiki
    Suzuki, Shigeaki
    Uzawa, Akiyuki
    Nagane, Yuriko
    Masuda, Masayuki
    Konno, Shingo
    Kubota, Tomoya
    Samukawa, Makoto
    Sugimoto, Takamichi
    Ishizuchi, Kei
    Oyama, Munenori
    Yasuda, Manato
    Akamine, Hiroyuki
    Onishi, Yosuke
    Suzuki, Yasushi
    Kawaguchi, Naoki
    Minami, Naoya
    Kimura, Takashi
    Takahashi, Masanori P.
    Murai, Hiroyuki
    Utsugisawa, Kimiaki
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2024, 11 (05): : 1338 - 1346
  • [8] REAL-WORLD EXPERIENCE OF ECULIZUMAB FOR MYASTHENIA GRAVIS
    Suh, J.
    Clarke, V.
    Guidon, A.
    MUSCLE & NERVE, 2020, 62 : S119 - S119
  • [9] Eculizumab Pharmacokinetics and Pharmacodynamics in Patients With Generalized Myasthenia Gravis
    Monteleone, Jonathan P. R.
    Gao, Xiang
    Kleijn, Huub Jan
    Bellanti, Francesco
    Pelto, Ryan
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [10] Eculizumab: A Review in Generalized Myasthenia Gravis
    Dhillon, Sohita
    DRUGS, 2018, 78 (03) : 367 - 376